VOYA Investment Management
CRBU icon

VOYA Investment Management’s Caribou Biosciences CRBU Stock Holding History

VOYA Investment Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25,165
Closed -$23K – 2674
2025
Q1 		$23K Sell
25,165
-1,413
-5% -$1.84K ﹤0.01% 2613
2024
Q4 		$42.3K Sell
26,578
-1,225
-4% -$2.46K ﹤0.01% 2704
2024
Q3 		$54.5K Hold
27,803
– – ﹤0.01% 2766
2024
Q2 		$45.6K Buy
27,803
+751
+3% +$2.4K ﹤0.01% 2798
2024
Q1 		$139K Sell
27,052
-5,632
-17% -$34.7K ﹤0.01% 2553
2023
Q4 		$187K Buy
32,684
+2,591
+9% +$12.8K ﹤0.01% 2593
2023
Q3 		$144K Buy
30,093
+7,526
+33% +$46.7K ﹤0.01% 2637
2023
Q2 		$95.9K Buy
22,567
+1,037
+5% +$4.66K ﹤0.01% 2798
2023
Q1 		$114K Hold
21,530
– – ﹤0.01% 2675
2022
Q4 		$135K Hold
21,530
– – ﹤0.01% 2682
2022
Q3 		$227K Buy
21,530
+1,292
+6% +$12K ﹤0.01% 2525
2022
Q2 		$110K Buy
+20,238
New +$155K ﹤0.01% 2588

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VOYA Investment Management's CRBU Position: Q2 2025 in Review

VOYA Investment Management sold out of Caribou Biosciences (CRBU) in Q2 2025, closing a stake of 25,165 shares — an estimated $23K sold.

VOYA Investment Management first reported a position in CRBU in Q2 2022 and held it in 12 quarters. The position peaked at $227K in Q3 2022. 129 funds tracked by Wall St. Rank hold CRBU as of Q2 2025.

  • VOYA Investment Management reported no remaining Caribou Biosciences position as of Q2 2025 after selling out during the quarter.
  • VOYA Investment Management sold 25,165 Caribou Biosciences shares in Q2 2025, an estimated $23K.
  • VOYA Investment Management first reported a position in Caribou Biosciences in Q2 2022 and held it in 12 quarters.
  • VOYA Investment Management's Caribou Biosciences position peaked at $227K in Q3 2022.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2025.

Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.